Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 22498879)

1.

CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells.

Liu J, Ma H, Wei T, Liang XJ.

Chem Commun (Camb). 2012 May 18;48(40):4869-71. doi: 10.1039/c2cc31697h. Epub 2012 Apr 12.

PMID:
22498879
2.

Development of stealth liposome coencapsulating doxorubicin and fluoxetine.

Ong JC, Sun F, Chan E.

J Liposome Res. 2011 Dec;21(4):261-71. doi: 10.3109/08982104.2010.545070. Epub 2011 Jan 12.

PMID:
21226547
3.

Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.

Paliwal SR, Paliwal R, Pal HC, Saxena AK, Sharma PR, Gupta PN, Agrawal GP, Vyas SP.

Mol Pharm. 2012 Jan 1;9(1):176-86. doi: 10.1021/mp200439z. Epub 2011 Nov 28.

PMID:
22091702
4.
5.

Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro.

Wang Y, Chen L, Ding Y, Yan W.

Int J Pharm. 2012 Jan 17;422(1-2):409-17. doi: 10.1016/j.ijpharm.2011.10.029. Epub 2011 Oct 20.

PMID:
22037443
6.

Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.

Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ.

J Pharm Pharm Sci. 2007;10(3):350-7.

7.

Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.

Obata Y, Tajima S, Takeoka S.

J Control Release. 2010 Mar 3;142(2):267-76. doi: 10.1016/j.jconrel.2009.10.023. Epub 2009 Oct 25.

PMID:
19861141
8.

Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.

Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H.

Int J Pharm. 2007 Feb 1;329(1-2):94-102. Epub 2006 Sep 1.

PMID:
16997518
9.

Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.

Mamasheva E, O'Donnell C, Bandekar A, Sofou S.

Mol Pharm. 2011 Dec 5;8(6):2224-32. doi: 10.1021/mp200079y. Epub 2011 Sep 21.

PMID:
21899300
11.

Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.

Thierry AR, Vigé D, Coughlin SS, Belli JA, Dritschilo A, Rahman A.

FASEB J. 1993 Apr 1;7(6):572-9.

12.

Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.

Sadasivan R, Morgan R, Fabian C, Stephens R.

Cancer Lett. 1991 May 1;57(2):165-71.

PMID:
1673873
13.

[The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].

Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q.

Yao Xue Xue Bao. 2005 May;40(5):475-80. Chinese.

PMID:
16220797
14.

Formation of transition metal-doxorubicin complexes inside liposomes.

Abraham SA, Edwards K, Karlsson G, MacIntosh S, Mayer LD, McKenzie C, Bally MB.

Biochim Biophys Acta. 2002 Sep 20;1565(1):41-54.

15.

Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery.

Geers B, Lentacker I, Sanders NN, Demeester J, Meairs S, De Smedt SC.

J Control Release. 2011 Jun 10;152(2):249-56. doi: 10.1016/j.jconrel.2011.02.024. Epub 2011 Feb 26.

PMID:
21362448
16.

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells.

Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM.

Biochim Biophys Acta. 2001 Dec 1;1515(2):144-58.

17.

Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.

Riganti C, Voena C, Kopecka J, Corsetto PA, Montorfano G, Enrico E, Costamagna C, Rizzo AM, Ghigo D, Bosia A.

Mol Pharm. 2011 Jun 6;8(3):683-700. doi: 10.1021/mp2001389. Epub 2011 May 5.

PMID:
21491921
19.
20.

Targeted magnetic liposomes loaded with doxorubicin.

Pradhan P, Banerjee R, Bahadur D, Koch C, Mykhaylyk O, Plank C.

Methods Mol Biol. 2010;605:279-93. doi: 10.1007/978-1-60327-360-2_19.

PMID:
20072888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk